Oriental Aromatics Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2025.
OAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 5.2 pts less than Nifty Microcap 250 and 4.7 pts less than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Oriental Aromatics reported Q1 FY26 standalone revenue of ₹22,513.44 lakhs, up about 4.3% from ₹21,575.82 lakhs in Q1 FY25. However, standalone net profit fell sharply to ₹573.50 lakhs from ₹1,164.47 lakhs, a decline of roughly 51%. Consolidated net profit collapsed even more dramatically to just ₹50.39 lakhs (vs ₹1,098.02 lakhs last year), as the new Mahad facility of wholly-owned subsidiary Oriental Aromatics & Sons Limited contributed losses of ₹524.96 lakhs since starting commercial production in November 2024. Finance costs nearly doubled on a consolidated basis (₹806.73 lakhs vs ₹405.52 lakhs), weighing further on profitability. Statutory auditor Lodha & Co LLP issued an unmodified review report on both standalone and consolidated results.
Revenue growth was modest while bottom-line performance weakened sharply, especially at the consolidated level, due to ramp-up losses at the new Mahad subsidiary and higher finance costs. Shareholders may view this as a transitional drag on earnings, though the standalone business remains profitable.